Skip to content
Tallac Therapeutics, Inc
Tallac Therapeutics, Inc

News

Home
News
Latest News

Latest News

In Latest NewsPosted December 1, 2020

Tallac Therapeutics Launches with $62 Million in Series A Financing to Advance Novel Immunotherapies for Cancer

More

Categories

  • Latest News (1)
  • Publication and Data (1)

Recent Posts

  • Tallac Therapeutics Launches with $62 Million in Series A Financing to Advance Novel Immunotherapies for Cancer
  • SITC 2020 Presentation

Archives

  • December 2020
  • November 2020
Tallac Therapeutics, Inc
  • (650) 866-1966
866 Malcolm Road Suite 100, Burlingame, CA 94010
Linkedin-in
Envelope

Copyright © 2020 Tallac Therapeutics, Inc. All Rights Reserved.